Status:
NOT_YET_RECRUITING
A Novel Method for Determination of Thromboembolic Stroke Origin
Lead Sponsor:
Atlantic Health System
Conditions:
Thromboembolic Stroke
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Rupture of vulnerable carotid, vertebral, and intracranial arterial plaques results in thromboembolic stroke. Identification of these culprit lesions is an important component of post-stroke care. Thi...
Eligibility Criteria
Inclusion
- 18 years of age or older with a non-cardiogenic thromboembolic stroke in the past 14 days.
Exclusion
- Less than 18 years of age, any other kind of stroke, not clinically stable to undergo PET-CT
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06961604
Start Date
June 1 2025
End Date
May 31 2026
Last Update
May 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Overlook Medical Center
Summit, New Jersey, United States, 07901